(Q40245352)

18 September 2017

title

Understanding the incremental value of novel diagnostic tests for tuberculosis (English)

1 reference

18 September 2017

1 reference

Nimalan Arinaminpathy

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26633767%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

author name string

David Dowdy

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26633767%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

language of work or name

English

0 references

publication date

1 December 2015

1 reference

18 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26633767%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

volume

528

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26633767%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

issue

7580

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26633767%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

page(s)

S60-7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26633767%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

8 June 2020

copyright license

start time

1 December 2015

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

World TB Day 2014: finding the missing 3 million

1 reference

https://api.crossref.org/works/10.1038%2FNATURE16045

Advances in tuberculosis diagnostics: the Xpert MTB/RIF assay and future prospects for a point-of-care test

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE16045

Fluorescence versus conventional sputum smear microscopy for tuberculosis: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE16045

Which new diagnostics for tuberculosis, and when?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE16045

Optimizing tuberculosis case detection through a novel diagnostic device placement model: the case of Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE16045

Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE16045

Impact of replacing smear microscopy with Xpert MTB/RIF for diagnosing tuberculosis in Brazil: a stepped-wedge cluster-randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE16045

Use of Xpert MTB/RIF in Decentralized Public Health Settings and Its Effect on Pulmonary TB and DR-TB Case Finding in India

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE16045

Do high rates of empirical treatment undermine the potential effect of new diagnostic tests for tuberculosis in high-burden settings?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE16045

The impact of novel tests for tuberculosis depends on the diagnostic cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE16045

Effect of empirical treatment on outcomes of clinical trials of diagnostic assays for tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE16045

Assessment of the patient, health system, and population effects of Xpert MTB/RIF and alternative diagnostics for tuberculosis in Tanzania: an integrated modelling approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE16045

The persistence of tuberculosis in the age of DOTS: reassessing the effect of case detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE16045

Is passive diagnosis enough? The impact of subclinical disease on diagnostic strategies for tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE16045

Modeling of novel diagnostic strategies for active tuberculosis - a systematic review: current practices and recommendations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE16045

Mathematical models in the evaluation of health programmes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE16045

Data needs for evidence-based decisions: a tuberculosis modeler's 'wish list'

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE16045

Prospects for worldwide tuberculosis control under the WHO DOTS strategy. Directly observed short-course therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE16045

The potential impact of enhanced diagnostic techniques for tuberculosis driven by HIV: a mathematical model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE16045

Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE16045

Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE16045

Rapid molecular detection of tuberculosis and rifampin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE16045

Estimating the costs of school closure for mitigating an influenza pandemic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE16045

Time delays in diagnosis of pulmonary tuberculosis: a systematic review of literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE16045

The importance of implementation strategy in scaling up Xpert MTB/RIF for diagnosis of tuberculosis in the Indian health-care system: a transmission model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE16045

The Potential Impact of Up-Front Drug Sensitivity Testing on India's Epidemic of Multi-Drug Resistant Tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE16045

The impact of new tuberculosis diagnostics on transmission: why context matters

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE16045

Transmission modeling and health systems: the case of TB in India

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE16045

New tuberculosis diagnostics and rollout

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE16045

Focusing technology assessment using medical decision theory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE16045

The evaluation of diagnostic tests: evidence on technical and diagnostic accuracy, impact on patient outcome and cost-effectiveness is needed.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE16045

Optimal triage test characteristics to improve the cost-effectiveness of the Xpert MTB/RIF assay for TB diagnosis: a decision analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE16045

Rapid molecular testing for TB to guide respiratory isolation in the U.S.: a cost-benefit analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE16045

Research on implementation of interventions in tuberculosis control in low- and middle-income countries: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE16045

Financial burden for tuberculosis patients in low- and middle-income countries: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE16045

A systematic review and meta-analysis of the impact of tuberculosis on health-related quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE16045

Latent Mycobacterium tuberculosis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE16045

Epidemiology of tuberculosis in a high HIV prevalence population provided with enhanced diagnosis of symptomatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE16045

Cross-sectional studies of tuberculosis prevalence in Cambodia between 2002 and 2011

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE16045

The impact of sputum quality on tuberculosis diagnosis: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE16045

Whole-genome sequencing and social-network analysis of a tuberculosis outbreak

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE16045

Prevalence of tuberculosis, HIV and respiratory symptoms in two Zambian communities: implications for tuberculosis control in the era of HIV

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE16045

Prevalence of tuberculosis in TB suspects with short duration of cough

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE16045

Towards tuberculosis elimination: an action framework for low-incidence countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE16045

Defining the needs for next generation assays for tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE16045

Tuberculosis and latent tuberculosis infection in close contacts of people with pulmonary tuberculosis in low-income and middle-income countries: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE16045

Progression of subclinical culture-positive tuberculosis to symptomatic disease in HIV-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE16045

Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE16045

Triage tests: a new priority for tuberculosis diagnostics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE16045

Potential market for novel tuberculosis diagnostics: worth the investment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE16045

Transmission of Mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE16045

Heterogeneity in tuberculosis transmission and the role of geographic hotspots in propagating epidemics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE16045

Scaling up Xpert MTB/RIF technology: the costs of laboratory- vs. clinic-based roll-out in South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE16045

Overcoming health-systems constraints to achieve the Millennium Development Goals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE16045

Xpert MTB/RIF testing in a low tuberculosis incidence, high-resource setting: limitations in accuracy and clinical impact.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE16045

Implementing rapid testing for tuberculosis in Mozambique

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE16045

Successes, challenges and lessons from a novel deployment of Xpert(®) MTB/RIF at a major South African public event [Short Communication].

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE16045

Xpert MTB/RIF false detection of rifampin-resistant tuberculosis from prior infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE16045

Clinical predictors and accuracy of empiric tuberculosis treatment among sputum smear-negative HIV-infected adult TB suspects in Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE16045

Impact of Xpert MTB/RIF testing on tuberculosis management and outcomes in hospitalized patients in Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE16045

Transforming the fight against tuberculosis: targeting catalysts of transmission.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE16045

Assessing spatial heterogeneity of multidrug-resistant tuberculosis in a high-burden country

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE16045

Contact investigations for outbreaks of Mycobacterium tuberculosis: advances through whole genome sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE16045

Evolutionary history and global spread of the Mycobacterium tuberculosis Beijing lineage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE16045

Transmission of Multidrug-Resistant and Drug-Susceptible Tuberculosis within Households: A Prospective Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE16045

Age-specific risks of tuberculosis infection from household and community exposures and opportunities for interventions in a high-burden setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE16045

Financing of global health: tracking development assistance for health from 1990 to 2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE16045

The economics of diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE16045

A systematic review of delay in the diagnosis and treatment of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE16045

7 January 2021

Yield of interview screening and chest X-ray abnormalities in a tuberculosis prevalence survey

1 reference

https://api.crossref.org/works/10.1038%2FNATURE16045

7 January 2021

Cost-effectiveness analysis in relation to budgetary constraints and reallocative restrictions

1 reference

https://api.crossref.org/works/10.1038%2FNATURE16045

7 January 2021

How much is tuberculosis screening worth? Estimating the value of active case finding for tuberculosis in South Africa, China, and India

1 reference

https://api.crossref.org/works/10.1038%2FNATURE16045

7 January 2021

Whole-genome sequencing of Mycobacterium tuberculosis as an epidemiological marker

1 reference

https://api.crossref.org/works/10.1038%2FNATURE16045

7 January 2021

Identifiers

DOI

10.1038/NATURE16045

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26633767%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

8 June 2020

1004936943

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26633767%20AND%20SRC:MED&resulttype=core&format=json